Adding a Medicine to the WHO Model List of Essential Medicines

被引：13

作者：

Kishore, S. P. ^{[1
]}

Herbstman, B. J. ^{[1
]}

机构：

[1] Weill Cornell Med Coll, New York, NY USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2009年 / 85卷 / 03期

关键词：

CORONARY-HEART-DISEASE; DEVELOPING-WORLD; CARDIOVASCULAR-DISEASE; TOTAL CHOLESTEROL; METAANALYSIS; MORTALITY; STATINS; STROKE;

D O I：

10.1038/clpt.2008.258

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Although the concept of essential medicines is not new, the processes that lead to placement of these medicines on the World Health Organization Model List of Essential Medicines are not well understood. here, we describe the process by which we added a class of drugs, statins, to the Model List to help combat the growing global epidemic of cardiovascular disease.

引用

页码：237 / 239

页数：3